REG - IXICO plc - Share Option Awards & PDMR Dealing

IXICOAnnouncement

31/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241031:nRSe3194Ka&default-theme=true

RNS Number : 3194K  IXICO plc  31 October 2024

31 October 2024

 

 

 

IXICO PLC

 

("IXICO" or the "Company")

 

Share Option Awards

PDMR Dealing

 

IXICO plc (AIM: IXI), the medical imaging advanced analytics company
delivering insights in neurosciences, today announces that, further to the
announcements made on 8 October 2024 in respect of the Company's proposal to
issue share options, and on 25 October 2024 in respect of the approval at the
General Meeting of the Company's new EMI Share Option Plan, the Company has
issued a total of 3,520,058 share options (the "Share Options") as follows:

 

Growth options:

 

Share Options over 2,780,058 shares have been awarded to the Bram Goorden, CEO
and Grant Nash, CFO of the Company.  These Growth Share Options have vesting
criteria aligned with retention and annual share price growth over 3 years.
Of these, 1,853,372 options (equivalent to 2% of issued share capital) have
been issued to the CEO, Bram Goorden, and 926,686 options (equivalent to 1% of
issued share capital) have been issued to the CFO, Grant Nash.  These options
have an exercise price of £0.01 and will be subject to a hold period to the
third anniversary of their award.

 

The achievement of share price growth each year shall be measured by
calculating the 3-month average share price immediately prior to each
anniversary of the option award.  The growth performance can be met in full
by an absolute compound share price growth of 40% over the three-year period
or in part by a 40% share price growth as compared to the prior year. In the
first year this shall be compared to a baseline price equivalent to the
three-month average share price immediately prior to the CEO joining the
Company on 19 August 2024.

 

Retention options:

 

Share Options over a further 740,000 shares are awarded to the broader
leadership team of the Company, including 200,000 Share Options awarded to the
Robin Wolz, CSO who is treated as a PDMR.  These Share Options have an
exercise price of £0.0925 and have vesting criteria aligned with retention of
these individuals in the business across 3 years.

 

 

 

For further information please contact:

 

 IXICO plc                                           +44 (0) 20 3763 7499
 Bram Goorden, Chief Executive Officer

 Grant Nash, Chief Financial Officer

 Cavendish Capital Markets Limited                   +44 (0) 20 7220 0500

 (Nominated adviser and sole broker)
 Giles Balleny / Dan Hodkinson (Corporate Finance)
 Nigel Birks (Life Sciences Specialist Sales)
 Harriet Ward (Corporate Broking)
 Michael F Johnson / Tamar Cranford Smith (Sales)

 

About IXICO

IXICO is dedicated to delivering insights in neuroscience to help transform
the advancement of investigational therapies for neurological diseases, such
as Huntington's disease, Parkinson's disease and Alzheimer's disease. The
Company's purpose is to advance medicine and human health by turning data into
clinically meaningful information, providing valuable new insights in
neuroscience by supporting pharmaceutical companies across all phases of CNS
clinical research. IXICO's goal is to be a leading advocate of artificial
intelligence in medical image analysis.

 

IXICO has developed and deployed breakthrough data analytics, at scale,
through its remote access technology platform, to improve the return on
investment in drug development and reduce risk and uncertainty in clinical
trials for the Company's pharmaceutical clients.

 

More information is available on www.IXICO.com (http://www.ixico.com/)  and
follow us on X (formerly Twitter) @IXICOnews

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Bram Goorden

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Options over ordinary shares in IXICO plc

      Identification code                                          ISIN: GB00BFXR4C20

 b)   Nature of the transaction                                    Grant of Share Options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     1 pence           1,853,372

 d)   Aggregated information

                                                                   N/A - single transaction
      - Aggregated volume

      - Price

 e)   Date of the transaction                                      30 October 2024

 f)   Place of the transaction                                     Off Market Transaction

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Grant Nash

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Options over ordinary shares in IXICO plc

      Identification code                                          ISIN: GB00BFXR4C20

 b)   Nature of the transaction                                    Grant of Share Options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     1 pence           926,686

 d)   Aggregated information

                                                                   N/A - single transaction
      - Aggregated volume

      - Price

 e)   Date of the transaction                                      30 October 2024

 f)   Place of the transaction                                     Off Market Transaction

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Robin Wolz

 2    Reason for the notification

 a)   Position/status                                              Chief Scientific Officer and PDMR

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Options over ordinary shares in IXICO plc

      Identification code                                          ISIN: GB00BFXR4C20

 b)   Nature of the transaction                                    Grant of Share Options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     9.25p             200,000

 d)   Aggregated information

      - Aggregated volume                                          N/A - single transaction

      - Price

 e)   Date of the transaction                                      30 October 2024

 f)   Place of the transaction                                     Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFDEEESELSEES